Inicio/Acciones/AURA

AURA

USD

Aura Biosciences Inc. Common Stock

$5.680-0.270 (-4.538%)

Precio en Tiempo Real

Healthcare

Biotecnología

Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado

Fundamentos de la Empresa

Estadísticas de Negociación

Métricas de Mercado

Apertura

$5.950

Máximo

$5.960

Mínimo

$5.630

Volumen

0.05M

Fundamentos de la Empresa

Capitalización de Mercado

352.8M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.24M

Bolsa

NGM

Moneda

USD

Rango de 52 Semanas

Mínimo $4.345Actual $5.680Máximo $11.29

Informe de Análisis de IA

Última actualización: 3 nov 2025

Generado por IAFuente de Datos: Yahoo Finance, Bloomberg, SEC

AURA Biosciences (AURA): Mixed Signals Near $6.10 Support Level

News Sentiment: Positive Catalysts Without Market Conviction

Aura Biosciences received two bullish signals from analysts and corporate events:

H.C. Wainwright Conference Participation (Sep 3): Failed to generate immediate momentum despite potential for investor visibility.
Analyst Buy Rating (Aug 13): Maintained a $22 price target--360% above current prices--but the stock hasn’t responded.

Market reaction to news appears muted. While analyst commentary remains optimistic, shares have traded flat-to

Noticias Relacionadas

3 sept 2025 · 11:00

GlobeNewswire

Aura Biosciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ:AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function,